Why the study?
Does a sintered platinum pacing lead improve acute and chronic electrical characteristics compared to an activated carbon pacing lead in patients requiring pacemakers?
Does a sintered platinum pacing lead improve acute and chronic electrical characteristics compared to an activated carbon pacing lead in patients requiring pacemakers?
Both sintered platinum and activated carbon pacing leads demonstrate excellent electrical performance, with statistically but not clinically significant differences in voltage thresholds.
Answers are grounded in this paper and cite their sources.
Both leads show excellent performance; supports equivalence but leaves open need for randomized confirmation.
A retrospective assessment was performed of the acute implantation characteristics of two pacing leads, one with a sintered platinum (S 80-T) electrode and the other with an activated vitreous carbon (412-S) electrode in 124 patients. The S80-T lead had a significantly lower implantation threshold. The differences between the two leads in sensing properties, in current flow at threshold voltage and at the output of the generator were not significant at implantation. The 412-S lead had a higher impedance measurement than the S-80-T at implantation but this was mainly due to the resistance differences of the conductors rather than to electrode-patient interactions. A subgroup of 20 patients had chronic threshold measurements. The S 80-T lead had a significantly lower chronic voltage threshold. However because the acute and chronic differences are small we conclude that, although these differences are statistically significant, they are not clinically significant. Both can justifiably be termed 'high-performance' leads.
No takes yet. Share an insight, caveat, or question.
Bourke et al. (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: